Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alessia Romagnoli"'
Autor:
Ruggero Lasala, Andrea Zovi, Valentina Isgrò, Alessia Romagnoli, Felice Musicco, Fiorenzo Santoleri
Publikováno v:
Current Medical Research and Opinion. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0e51dceaef34c473b717a50feccea7
https://doi.org/10.1080/03007995.2023.2192610
https://doi.org/10.1080/03007995.2023.2192610
Autor:
Felice Musicco, Ruggero Lasala, Fiorenzo Santoleri, Alberto Costantini, Paolo Abrate, Maria Teresa Carretta, Enrica Maria Proli, Alessia Romagnoli, Nicola Petragnani, Francesco De Vita, Massimo Zeuli, Patrizia Vici, Massimo Sansone, Matilde Pasquantonio, Antonia La Malfa, Chiara Fulgenzio
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Objective Palbociclib, a highly selective reversible CDK4-6 kinase inhibitor, is indicated in combination with an aromatase inhibitor or in combination with fulvestrant in women who had received prior endocrine treatment. Studies have demonstrated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45a3aa7a60b8535c65f410cd565ec4a
https://pubmed.ncbi.nlm.nih.gov/35903919
https://pubmed.ncbi.nlm.nih.gov/35903919
Publikováno v:
Current Reviews in Clinical and Experimental Pharmacology. 16:109-116
Background: Persistence and adherence to treatment are considered efficacy outcomes in psychiatric disorders. One of the best ways to improve these values in patients with psychiatric disorders is to prefer Long-Acting Injectable (LAI) drugs to oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e18c23d89b4ebccf4d5c4e12cd33b69
https://doi.org/10.2174/1574884715666200309121932
https://doi.org/10.2174/1574884715666200309121932
Publikováno v:
Current Medical Research and Opinion. 36:2055-2061
Low adherence and persistence values, which indicate real-life efficiency, have been widely reported in patients suffering from COPD (Chronic Obstructive Pulmonary Disease). Poor adherence may be related to treatment dosage, thus, simplifying the dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93c035eaaed1a27a861b102f387db89
https://doi.org/10.1080/03007995.2020.1841617
https://doi.org/10.1080/03007995.2020.1841617
Publikováno v:
Current medical research and opinion. 38(2)
INTRODUCTION At this time in history fraught with restrictions and issues stemming from the COVID-19 pandemic, the care and management of chronic therapies is a major concern for society. The objective of the following study was to assess whether adh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39ab4354b560668535467c5276deb5d
https://pubmed.ncbi.nlm.nih.gov/34850662
https://pubmed.ncbi.nlm.nih.gov/34850662
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016
Autor:
Alberto Costantini, Alessia Romagnoli, Felice Musicco, Paolo Abrate, Ruggero Lasala, Davide Zanon, Fiorenzo Santoleri
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
Background The treatment options available to children with cancer are limited. This is why for more than 10 years, the European Medicine Agency (EMA) has stated that all drugs to be marketed must be tested on the paediatric population in accordance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e8618adf38ca5362f668ec04f7e381
https://pubmed.ncbi.nlm.nih.gov/34693799
https://pubmed.ncbi.nlm.nih.gov/34693799
Publikováno v:
Current medical research and opinion. 37(12)
Adherence and persistence to treatment are crucial in statin therapy as they are synonymous with efficacy and quality of care. The aim of this study was the real-life assessment of adherence and persistence over eight years in treatment-naive patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea5bacdf7badce203dd24f4b2fa3ceac
https://pubmed.ncbi.nlm.nih.gov/34515600
https://pubmed.ncbi.nlm.nih.gov/34515600
Autor:
Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Paolo Abrate, Felice Musicco, Alberto Costantini
Publikováno v:
European journal of hospital pharmacy : science and practice.
To assess how and to what extent adherence to medication is reported in pivotal clinical trials of oral cancer drugs.All drugs authorised by the European Medicines Agency from 1 January 2014 to 31 December 2019 were considered for analysis. For each
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd4693a0ffc179522ac693c5fbccb1c
https://pubmed.ncbi.nlm.nih.gov/35058307
https://pubmed.ncbi.nlm.nih.gov/35058307
Publikováno v:
Expert Opinion on Drug Safety. 19:93-97
Objectives: The objective of this study was to calculate adherence, persistence and 10-year switches in patients with PsA, by comparing adalimumab and etanercept in real life.Methods: The authors conducted a retrospective, observational, pharmacologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7259c7ce1ccde8f075597f356caafe88
https://doi.org/10.1080/14740338.2020.1681396
https://doi.org/10.1080/14740338.2020.1681396
Publikováno v:
Future Oncology. 15:45-51
The aim of this retrospective study is to evaluate adherence, switch and costs a year after the start of treatment with different erythropoietin-stimulating agents. There were 277 patients, 200 were originators (72.20%) and 77 (27.80%) were biosimila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bcbe9bad10b2f3b55a3d071a440c407
https://doi.org/10.2217/fon-2018-0333
https://doi.org/10.2217/fon-2018-0333